During the past decade, SalaUno Salud, S.A.P.I. de C.V. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SalaUno Salud, S.A.P.I. de C.V." are "Age-related Cataract" (1 trials), "Diabetic Macular Edema" (1 trials) and "Phacoemulsification" (1 trials). Many other conditions were trialed in "SalaUno Salud, S.A.P.I. de C.V." in a lesser frequency.

Most popular intervention types in "SalaUno Salud, S.A.P.I. de C.V." are "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Lucentis®" (1 trials) and "Sodium hyaluronate 3%" (1 trials). Other intervention names were less common.

The vast majority of trials in "SalaUno Salud, S.A.P.I. de C.V." are 2 trials for "All" genders.

Currently, there are NaN active trials in "SalaUno Salud, S.A.P.I. de C.V.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in SalaUno Salud, S.A.P.I. de C.V., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SalaUno Salud, S.A.P.I. de C.V., 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".